| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.059 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |